GlassScriptPhysician profile
Susan M Dindot
NPI 1821279225
$2,624.67
in general payments reported to CMS, 2019-2025
30 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.33 · 2021: $116 · 2022: $613 · 2023: $1,038 · 2024: $485 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $425.97 | 2023-2025 | Trelegy Ellipta, Nucala |
| Lilly USA, LLC | $378.24 | 2021-2025 | Mounjaro, Trulicity, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $264.45 | 2022-2024 | Glassia, Cuvitru, Hyqvia |
| Grifols USA, LLC | $155.13 | 2022-2023 | Prolastin-C Liquid |
| Amgen INC. | $153.41 | 2022-2023 | Repatha |
| Abbvie INC. | $151.24 | 2021-2024 | Ubrelvy, Qulipta |
| Genzyme Corporation | $119.48 | 2021-2025 | |
| Mylan Specialty L.P. | $94.85 | 2023-2024 | Yupelri |
| Novo Nordisk INC | $89.84 | 2019-2024 | Wegovy, Saxenda |
| Merck Sharp & Dohme LLC | $88.39 | 2022-2025 | Winrevair, Gardasil, Capvaxive |
| Baxter Healthcare | $70.57 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $53.38 | 2023 | Uptravi, Opsumit |
| Exact Sciences Corporation | $52.15 | 2023-2024 | Cologuard Collection Kit |
| Harmony Biosciences LLC | $49.96 | 2022 | |
| Axsome Therapeutics, INC. | $47.13 | 2023 | Sunosi |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $45.84 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $42.22 | 2022-2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $41.77 | 2023 | Farxiga |
| Sanofi Pasteur INC. | $36.51 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.51 | 2023 | Xifaxan |
| Ani Pharmaceuticals, INC. | $33.57 | 2025 | Purified Cortrophin Gel |
| Almatica Pharma LLC | $30.66 | 2023 | Loreev Xr |
| Medtronic USA, INC. | $27.70 | 2019 | |
| Corcept Therapeutics | $24.41 | 2025 | Korlym |
| Alexion Pharmaceuticals, INC. | $21.52 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.78 | 2023 | Xarelto |
| Paratek Pharmaceuticals, INC. | $19.99 | 2025 | Nuzyra |
| Philips North America LLC | $19.53 | 2022 | |
| Cmp Pharma, INC. | $16.60 | 2024 | Liqrev, Atorvaliq, Carospir |
| Edwards Lifesciences Corporation | $12.87 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Dindot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.